Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases
Clinical trial NCT04463368 · COMPLETED
Trial details
- NCT number
- NCT04463368
- Sponsor
- Vastra Gotaland Region
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2024-07-26
- Enrollment
- 18
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.